Deep Margin podcast

Episode 21: Alan Ho live (post hoc) from the Multidisciplinary Head and Neck Cancers Symposium

5/31/2026
0:00
39:56
Rewind 15 seconds
Fast Forward 15 seconds

Alan Ho, Medical oncologist at MSKCC talks us through his work around Ozuriftamab Vedotin (Oz-V) and other ADC approaches. Ben criticises Will's combination approaches.

More episodes from "Deep Margin"